Socioeconomic status, p53 abnormalities, and colorectal cancer

Journal of Gastrointestinal Oncology

Volumn 4, Issue 1, 2013, Pages 40-44

  Vogtmann, Emily ^a   Shanmugam, Chandrakumar ^b   Katkoori, Venkat R ^c   Waterbor, John ^a   Manne, Upender ^a,b  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^b University of Alabama at Birmingham   (United States)

^c MICHIGAN STATE UNIVERSITY   (United States)

Author keywords

Colorectal cancer; Employment status; Health insurance; P53 abnormalities; Socio economic status

Indexed keywords

PROTEIN P53;

ADULT; AGED; ARTICLE; COHORT ANALYSIS; COLORECTAL CANCER; CONTROLLED STUDY; DISABILITY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; MEDICAID; MEDICAL RECORD; MEDICARE; OVERALL SURVIVAL; PILOT STUDY; POPULATION RESEARCH; PREVALENCE; PRIVATE HEALTH INSURANCE; PROTEIN EXPRESSION; SOCIAL STATUS; UNEMPLOYMENT;

EID: 84995757405     PISSN: 20786891     EISSN: 2219679X     Source Type: Journal    
DOI: 10.3978/j.issn.2078-6891.2012.054     Document Type: Article

References (19)

1. American Cancer Society. Facts and Figures 2011-2013. Atlanta, GA, 2011:1-64.
2. Altekruse SF, Kosary CL, Krapcho M, et al. SEER Cancer Statistics Review, 1975-2007. Bethesda, MD. National Cancer Institute, 2009.
3. Paquette I, Finlayson SR. Rural versus urban colorectal and lung cancer patients: differences in stage at presentation. J Am Coll Surg 2007;205:636-41.
4. Du XL, Fang S, Vernon SW, et al. Racial disparities and socioeconomic status in association with survival in a large population-based cohort of elderly patients with colon cancer. Cancer 2007;110:660-9.
5. Parikh-Patel A, Bates JH, Campleman S. Colorectal cancer stage at diagnosis by socioeconomic and urban/rural status in California, 1988-2000. Cancer 2006;107:1189-95.
6. Goh HS, Yao J, Smith DR. p53 point mutation and survival in colorectal cancer patients. Cancer research 1995;55:5217-21.
7. Hollstein M, Sidransky D, Vogelstein B, et al. p53 mutations in human cancers. Science 1991;253:49-53.
8. Manne U, Myers RB, Moron C, et al. Prognostic significance of Bcl-2 expression and p53 nuclear accumulation in colorectal adenocarcinoma. Int J Cancer 1997;74:346-58.
9. Manne U, Weiss HL, Myers RB, et al. Nuclear accumulation of p53 in colorectal adenocarcinoma: prognostic importance differs with race and location of the tumor. Cancer 1998;83:2456-67.
10. Williams DR, Mohammed SA, Leavell J, et al. Race, socioeconomic status, and health: complexities, ongoing challenges, and research opportunities. Ann N Y Acad Sci 2010;1186:69-101.
11. Baker L, Quinlan PR, Patten N, et al. p53 mutation, deprivation and poor prognosis in primary breast cancer. Br J Cancer 2010;102:719-26.
12. Grizzle WE, Myers RB, Manne U, et al. Immunohistochemical evaluation of biomarkers in prostatic and colorectal neoplasia. In: Hanausek M, Walaszek Z, eds. John Walker's Methods in Molecular Medicine-Tumor Marker Protocols. Totowa, NJ: Humana Press, 1998:143-60.
13. Edge SB, Byrd DR, Compton CC, et al. eds. American Joint Committee on Cancer, American Cancer Society: AJCC Cancer Staging Manual. 7th ed. New York, NY: Springer-Verlag, 2010.
14. Claxton G, DiJulio B, Whitmore H, et al. Health benefits in 2010: premiums rise modestly, workers pay more toward coverage. Health Aff (Millwood) 2010;29:1942-50.
15. Shaulsky G, Goldfinger N, Ben-Ze'ev A, et al. Nuclear accumulation of p53 protein is mediated by several nuclear localization signals and plays a role in tumorigenesis. Mol Cell Biol 1990;10:6565-77.
16. Jia L, Liu Y, Yi X, et al. Endometrial glandular dysplasia with frequent p53 gene mutation: a genetic evidence supporting its precancer nature for endometrial serous carcinoma. Clin Cancer Res 2008;14:2263-9.
17. Grizzle WE, Myers RB, Manne U, et al. Factors affecting immunohistochemical evaluation of biomarker expression in neoplasia. In: Hanausek M, Walaszek Z, editors. John Walker's Methods in Molecular Medicine - Tumor Marker Protocols. Totowa, NJ: Humana Press, 1998:161-79.
18. Manne U. Understanding racial differences in colorectal cancer aids in individualized medicine. Future Oncol 2007;3:235-41.
19. Krieger N, Quesenberry C Jr, Peng T, et al. Social class, race/ethnicity, and incidence of breast, cervix, colon, lung, and prostate cancer among Asian, Black, Hispanic, and White residents of the San Francisco Bay Area, 1988-92 (United States). Cancer Causes Control 1999;10:525-37.